MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.
PETALING JAYA: Positive developments in the development of a Covid-19 vaccine will continue to lift interest in local pharmaceutical manufacturers, including Pharmaniaga Bhd
, which is touted to be among the frontrunners to win a tender for the vaccine.
MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
